Technology | Fusion Imaging Software | January 03, 2017

New bkFusion solution will allow more accurate and reliable biopsy results than ultrasound-only transrectal biopsy

MIM Software, BK Ultrasound, bkFusion, MRI Fusion Biopsy System, prostate cancer, RSNA 2016

January 3, 2017 —  MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate Fusion Software as a fully integrated software on BK Ultrasound’s premium bk3000 ultrasound system. The global launch of this solution for prostate biopsy, bkFusion, was developed in partnership between the companies.

bkFusion is built on MIM Software’s multi-modality image fusion capabilities. In creating bkFusion, MIM Software leveraged its patented Predictive Fusion technology for MRI prostate fusion during biopsy. Predictive Fusion “reslices” and pre-aligns the MRI images to correspond to the prostate’s orientation during the biopsy and then fuses them to the ultrasound images at the time of biopsy, saving time during the procedure. This advancement in MRI targeting assists the practitioner in achieving a higher prostate cancer detection rate when compared to traditional ultrasound-only transrectal biopsy. Patients will benefit from a more accurate and reliable biopsy when prostate cancer is present.

The bkFusion solution, consisting of the bk3000 ultrasound system along with the E14C4t Prostate Triplane transducer, will provide an MRI Fusion Biopsy System with the smallest footprint in the industry, according to the companies. The bk3000 fits easily into any office space and because bkFusion is completely integrated on the ultrasound system, no additional bulky equipment or setup time is required. The system communicates easily with radiology departments, accessing the MRI images via picture archiving and communication system (PACS) or a secure cloud platform. Alternatively, with the BK Flex Focus ultrasound product line, BK Ultrasound will offer a laptop-based bkFusion application. Both the integrated application and laptop version will provide the same user interface, workflow and reporting.

MIM will continue to develop and distribute its MIM Symphony Dx advanced MRI prostate visualization and analysis software for radiologists. Software features include prostate MRI review, linking, contouring and reporting capabilities. MIM Symphony Dx includes tools for quantitative longitudinal analysis, linking of biopsy results and locations with MR, and sophisticated reporting. MIM Symphony Dx and bkFusion share a common platform and will allow seamless communication either directly, via MIMcloud, or through external drives.

BK Ultrasound will distribute bkFusion for use with its bk3000 and Flex Focus ultrasound systems in the United States. BK Ultrasound has undertaken registration globally and will distribute the solutions through its global network.

For more information: www.mimsoftware.com


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Radiology Business

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Feature | Women's Health | By Jordan Bazinsky

Investing in women’s health should not merely be a metric on the equity dashboard — it should drive policy and tactical ...

Time July 08, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
News | Pediatric Imaging

June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...

Time June 25, 2024
arrow
Subscribe Now